Search Results

There are 3736 results for: content related to: Peginterferon for chronic hepatitis B: Predicting success with on-treatment benchmarks

  1. You have free access to this content
    Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Goran Hauser, Tahany Awad, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk and Christian Gluud

    Published Online : 28 FEB 2014, DOI: 10.1002/14651858.CD005642.pub3

  2. You have free access to this content
    Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud and Lise Lotte Gluud

    Published Online : 28 FEB 2014, DOI: 10.1002/14651858.CD005441.pub3

  3. Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus

    Intervention Review

    The Cochrane Library

    Alfonso Iorio, Emanuela Marchesini, Tahany Awad and Lise Lotte Gluud

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD004888.pub2

  4. On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1540–1548, Ioannis Goulis, Stylianos Karatapanis, Evangelos Akriviadis, Melanie Deutsch, George N. Dalekos, Maria Raptopoulou-Gigi, Konstantinos Mimidis, George Germanidis, Christos Drakoulis, Christos Triantos, Elias Zintzaras, Georgios Bakalos and George Papatheodoridis

    Version of Record online : 20 NOV 2014, DOI: 10.1111/liv.12725

  5. Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: e81–e90, S. Mauss, D. Hueppe, C. John, J Goelz, R. Heyne, B. Moeller, R. Link, G. Teuber, A. Herrmann, M. Spelter, S. Wollschlaeger, A. Baumgarten, K.-G. Simon, N. Dikopoulos and T. Witthoeft

    Version of Record online : 16 SEP 2010, DOI: 10.1111/j.1365-2893.2010.01372.x

  6. Current Therapies for Chronic Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 1, January 2011, Pages: 92–111, McKenzie C. Ferguson

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.31.1.92

  7. You have full text access to this OnlineOpen article
    Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study

    British Journal of Clinical Pharmacology

    Volume 79, Issue 3, March 2015, Pages: 514–522, Xiao Hu, Yue Cui, Joleen White, Ying Zhu, Aaron Deykin, Ivan Nestorov and Serena Hung

    Version of Record online : 20 FEB 2015, DOI: 10.1111/bcp.12521

  8. You have free access to this content
    Hepatitis C virus: How genetic variability affects pathobiology of disease

    Journal of Gastroenterology and Hepatology

    Volume 26, Issue s1, January 2011, Pages: 83–95, Kazuaki Chayama and C Nelson Hayes

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1440-1746.2010.06550.x

  9. You have free access to this content
    Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1141–1150, Maurizia Rossana Brunetto, Francesco Moriconi, Ferruccio Bonino, George K. K. Lau, Patrizia Farci, Cihan Yurdaydin, Teerha Piratvisuth, Kangxian Luo, Yuming Wang, Stephanos Hadziyannis, Eva Wolf, Philip McCloud, Richard Batrla and Patrick Marcellin

    Version of Record online : 2 DEC 2008, DOI: 10.1002/hep.22760

  10. You have free access to this content
    Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 3, August 2007, Pages: 369–376, R. BRUNO, P. SACCHI, C. SCAGNOLARI, F. TORRIANI, L. MAIOCCHI, S. PATRUNO, F. BELLOMI, G. FILICE and G. ANTONELLI

    Version of Record online : 29 MAY 2007, DOI: 10.1111/j.1365-2036.2007.03392.x

  11. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22017

  12. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients

    Intervention Review

    The Cochrane Library

    Lior H Katz, Hadar Goldvaser, Anat Gafter-Gvili and Ran Tur-Kaspa

    Published Online : 12 SEP 2012, DOI: 10.1002/14651858.CD008516.pub2

  13. Telaprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 10, October 2011, Pages: 951–974, Olga M. Klibanov, Shannon H. Williams, Lisa S. Smith, Jacqueline L. Olin and Stephen B. Vickery

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.31.10.951

  14. Peginterferon alfa-2a versus Peginterferon alfa-2b as Initial Treatment of Hepatitis C Virus Infection: A Cost-Utility Analysis from the Perspective of the Veterans Affairs Health Care System

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 6, June 2007, Pages: 813–824, Wei-Shi Yeh, Edward P. Armstrong, Grant H. Skrepnek and Daniel C. Malone

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.6.813

  15. The Effect of Multiple Doses of Peginterferon alfa-2b on the Steady-State Pharmacokinetics of Methadone in Patients With Chronic Hepatitis C Undergoing Methadone Maintenance Therapy

    The Journal of Clinical Pharmacology

    Volume 47, Issue 5, May 2007, Pages: 604–612, Dr Samir K. Gupta, Dr Edward Sellers, Dr Eugene Somoza, Dr Luis Angles, Dr Karen Kolz and Dr David L. Cutler

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007299760

  16. You have free access to this content
    Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 5, March 2008, Pages: 433–440, V. K. RUSTGI, S. ESPOSITO, F. M. HAMZEH and M. L. SHIFFMAN

    Version of Record online : 10 DEC 2007, DOI: 10.1111/j.1365-2036.2007.03587.x

  17. You have free access to this content
    Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

    Hepatology

    Volume 52, Issue 2, August 2010, Pages: 454–461, Vincent Rijckborst, Bettina E. Hansen, Yilmaz Cakaloglu, Peter Ferenci, Fehmi Tabak, Meral Akdogan, Krzysztof Simon, Ulus S. Akarca, Robert Flisiak, Elke Verhey, Anneke J. Van Vuuren, Charles A. B. Boucher, Martijn J. ter Borg and Harry L. A. Janssen

    Version of Record online : 19 APR 2010, DOI: 10.1002/hep.23722

  18. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 14, Issue 10, October 2007, Pages: 721–729, A. M. Di Bisceglie, R. H. Ghalib, F. M. Hamzeh and V. K. Rustgi

    Version of Record online : 26 APR 2007, DOI: 10.1111/j.1365-2893.2007.00862.x

  19. You have free access to this content
    High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials

    Hepatology

    Volume 56, Issue 6, December 2012, Pages: 2039–2050, Patrick Marcellin, Hugo Cheinquer, Manuela Curescu, Geoffrey M. Dusheiko, Peter Ferenci, Andrzej Horban, Donald Jensen, Gabriella Lengyel, Alessandra Mangia, Denis Ouzan, Massimo Puoti, Maribel Rodriguez-Torres, Mitchell L. Shiffman, Manuela Schmitz, Fernando Tatsch and Mario Rizzetto

    Version of Record online : 8 AUG 2012, DOI: 10.1002/hep.25892

  20. You have free access to this content
    Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin

    Hepatology

    Volume 56, Issue 2, August 2012, Pages: 464–473, Stephen A. Harrison, Fayez M. Hamzeh, Jian Han, Prashant K. Pandya, Muhammed Y. Sheikh and John M. Vierling

    Version of Record online : 11 JUN 2012, DOI: 10.1002/hep.25661